中国生物制药(01177.HK)拟3月26日举行董事会会议以审批年度业绩

Core Viewpoint - China Biologic Products Holdings (01177.HK) announced that it will hold a board meeting on March 26, 2026, to approve the annual results for the year ending December 31, 2025, and to consider the proposal for the final dividend distribution, if any [1] Group 1 - The board meeting is scheduled for March 26, 2026 [1] - The meeting will focus on approving the annual performance results for the year ending December 31, 2025 [1] - The company will also consider the proposal for the final dividend distribution during this meeting [1]